Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities

Background: Management of beta-thalassemia major (TM) requires life-long hemotransfusions leading to iron overload. Iron elimination is enhanced by the use of modern chelators. Aim: To assess the effect of modern chelation therapy by dynamics of serum ferritin concentration and liver MR...

Full description

Bibliographic Details
Main Authors: Pencho G. Georgiev, Katya G. Sapunarova, Veselina S. Goranova-Marinova, Stefan E. Goranov
Format: Article
Language:English
Published: Pensoft Publishers 2020-06-01
Series:Folia Medica
Subjects:
fer
Online Access:https://foliamedica.bg/article/39518/download/pdf/
id doaj-f798d8d79a6f40c2951fc36976559d14
record_format Article
spelling doaj-f798d8d79a6f40c2951fc36976559d142020-11-25T03:12:25ZengPensoft PublishersFolia Medica 1314-21432020-06-0162226527010.3897/folmed.62.e3951839518Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation ModalitiesPencho G. Georgiev0Katya G. Sapunarova1Veselina S. Goranova-Marinova2Stefan E. Goranov3Clinical Hematology Clinic, St George University Hospital, Medical University of PlovdivHematology Section, First Department of Internal Medicine, Medical University of PlovdivClinical Hematology Clinic, St George University Hospital, Medical University of PlovdivHematology Section, First Department of Internal Medicine, Medical University of PlovdivBackground: Management of beta-thalassemia major (TM) requires life-long hemotransfusions leading to iron overload. Iron elimination is enhanced by the use of modern chelators. Aim: To assess the effect of modern chelation therapy by dynamics of serum ferritin concentration and liver MRI T2*.Patients and methods: Forty-six patients with TM (male to female ratio =1:1, mean age 33.2±10.9 years) were prospectively studied between 2011 and 2014. Twenty-one patients (45.7%) were treated with deferasirox, 17 (37%) – with deferiprone, and 8 (17.3%) – with deferiprone in combination with deferoxamine. Ferritin was measured by ELISA. MRI T2* was assessed by Siemens Magnetom Avanto 1.5T. The patients were allocated into 3 groups based on their initial ferritin level and liver MRI T2*. Statistical analysis was performed using SPSS v. 18 for Windows. Data were analysed by descriptive analysis, analysis of variance and correlative analysis, means were compared using t-test and one-way ANOVA.Results: In 2011, 9 (19.5%) patients had normal liver MRI T2*; in 2014 they were 17 (37%). The patients with mild grade liver siderosis were 12 (26%) in 2011, and in 2014 they were 14 (30.4%). In 2011, the patients with moderate liver siderosis were 14 (30.4%), and in 2014 – 12 (26.0%). Eleven patients (23.9%) had severe liver siderosis in 2011 and only two patients (4.0%) were diagnosed with the condition in 2014.Conclusion: A reduction of iron overload was found in all studied groups. This positive effect is attributed to the use of modern chelators and the ease of access to accurate monitoring.https://foliamedica.bg/article/39518/download/pdf/beta-thalassemia majorhepatic iron overloadfer
collection DOAJ
language English
format Article
sources DOAJ
author Pencho G. Georgiev
Katya G. Sapunarova
Veselina S. Goranova-Marinova
Stefan E. Goranov
spellingShingle Pencho G. Georgiev
Katya G. Sapunarova
Veselina S. Goranova-Marinova
Stefan E. Goranov
Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities
Folia Medica
beta-thalassemia major
hepatic iron overload
fer
author_facet Pencho G. Georgiev
Katya G. Sapunarova
Veselina S. Goranova-Marinova
Stefan E. Goranov
author_sort Pencho G. Georgiev
title Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities
title_short Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities
title_full Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities
title_fullStr Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities
title_full_unstemmed Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities
title_sort reduction of liver iron load in adult patients with β-thalassemia major treated with modern chelation modalities
publisher Pensoft Publishers
series Folia Medica
issn 1314-2143
publishDate 2020-06-01
description Background: Management of beta-thalassemia major (TM) requires life-long hemotransfusions leading to iron overload. Iron elimination is enhanced by the use of modern chelators. Aim: To assess the effect of modern chelation therapy by dynamics of serum ferritin concentration and liver MRI T2*.Patients and methods: Forty-six patients with TM (male to female ratio =1:1, mean age 33.2±10.9 years) were prospectively studied between 2011 and 2014. Twenty-one patients (45.7%) were treated with deferasirox, 17 (37%) – with deferiprone, and 8 (17.3%) – with deferiprone in combination with deferoxamine. Ferritin was measured by ELISA. MRI T2* was assessed by Siemens Magnetom Avanto 1.5T. The patients were allocated into 3 groups based on their initial ferritin level and liver MRI T2*. Statistical analysis was performed using SPSS v. 18 for Windows. Data were analysed by descriptive analysis, analysis of variance and correlative analysis, means were compared using t-test and one-way ANOVA.Results: In 2011, 9 (19.5%) patients had normal liver MRI T2*; in 2014 they were 17 (37%). The patients with mild grade liver siderosis were 12 (26%) in 2011, and in 2014 they were 14 (30.4%). In 2011, the patients with moderate liver siderosis were 14 (30.4%), and in 2014 – 12 (26.0%). Eleven patients (23.9%) had severe liver siderosis in 2011 and only two patients (4.0%) were diagnosed with the condition in 2014.Conclusion: A reduction of iron overload was found in all studied groups. This positive effect is attributed to the use of modern chelators and the ease of access to accurate monitoring.
topic beta-thalassemia major
hepatic iron overload
fer
url https://foliamedica.bg/article/39518/download/pdf/
work_keys_str_mv AT penchoggeorgiev reductionofliverironloadinadultpatientswithampbetathalassemiamajortreatedwithmodernchelationmodalities
AT katyagsapunarova reductionofliverironloadinadultpatientswithampbetathalassemiamajortreatedwithmodernchelationmodalities
AT veselinasgoranovamarinova reductionofliverironloadinadultpatientswithampbetathalassemiamajortreatedwithmodernchelationmodalities
AT stefanegoranov reductionofliverironloadinadultpatientswithampbetathalassemiamajortreatedwithmodernchelationmodalities
_version_ 1724650416353837056